Monash Phage Foundry

Monash Phage Foundry (MPF)

The Centre to Impact AMR has assembled a team of world-renowned bacteriophage (phage) experts to create a unique Monash Phage Foundry.

The MPF is supplying therapeutic phages to the clinical referral service 'Victorian Phage Therapy Service' (VicPhage) with the support of The Alfred.

We will also service other hospital partners in the Phage Australia Network and other industry sectors with phages and phage-derived products.

Monash Phage Foundry Phage Production Facility	VICPhage Bacteriophage Therapy Referral Service
Associate Professor Jeremy Barr School of Biological Sciences, Faculty of Science, Monash University Phage Biology \| Phage Discovery \| Phage Production for treatment of Infections Contact: Jeremy.Barr@monash.edu	Professor Anton Peleg Department of Infectious Diseases, The Alfred Hospital and Monash University Clinical Lead \| Infectious Diseases Clinician \| Phage Therapy Contact: Anton.Peleg@monash.edu More Information

Monash Phage Foundry
Phage Production Facility

VICPhage
Bacteriophage Therapy Referral Service

Associate Professor Jeremy Barr

School of Biological Sciences, Faculty of Science, Monash University

Phage Biology | Phage Discovery | Phage Production for treatment of Infections

Contact: Jeremy.Barr@monash.edu

Professor Anton Peleg

Department of Infectious Diseases, The Alfred Hospital and Monash University

Clinical Lead | Infectious Diseases Clinician | Phage Therapy

Contact: Anton.Peleg@monash.edu

More Information

Monash Bacteriophage research groups	Monash Bacteriophage research groups
Professor Trevor Lithgow Phage Discovery from under-sampled environments \| Phage genomics and structural biology \| Phage binding and adaption to bacterial surfaces \| Biobanking	Professor Jian Li Innovative phage therapy against multidrug-resistant P. aeruginosa, A. baumannii and K. pneumoniae
Associate Professor Jiangning Song Artificial intelligence systems for phage characterization and deployment	Dr Rhys Dunstan Artificial intelligence systems for phage characterization and deployment
Associate Professor Mike McDonald Phage Evolution \| Phage-Bacterial Host Co-Evolution \| Phage resistance \| Phage as a tool for microbial community engineering	Dr Tze Thung Phage Evolution \| Phage-Bacterial Host Co-Evolution \| Phage resistance \| Phage as a tool for microbial community engineering
Dr Sue Nang Development of therapeutic phages \| Drug-resistant P. aeruginosa, A. baumannii and K. pneumoniae

VICPhage - Bacteriophage Therapy Referral Service

Phage therapy is an experimental method that is only available when all other approaches are already optimised and only under the auspices of a special access scheme defined by the Therapeutic Goods Administration or within a clinical trial.

If a TGA-approved indication exists, we follow a protocol that has been defined by consensus among expert physicians and may evolve over time as data are reviewed. Professor Anton Peleg, Director of Infectious Diseases at the Alfred hospital is making Phage Therapy a reality for Victoria patients.

At this time, Phage therapy is only available to patients meeting certain medical criteria. Referrals to Anton and his team should be made through your family doctor or an infectious diseases specialist.

The process to be eligible for treatment is below.

If you believe that you or a family member may be a suitable candidate for phage therapy, please see your family doctor in the first instance to discuss this and request a referral to an adult or paediatric infectious disease specialist.
If your Infection specialist can certify that all medical and surgical anti-infection strategies are optimised or exhausted, they may suggest a referral to one of our team for discussion.
If you meet all are requirements and are eligible for phage therapy there will be a requirement that non-phage anti-infective strategies be closely and independently monitored during the course of phage therapy and there will be a follow-up period of several weeks thereafter.

If you are eligible to receive therapy, we require informed consent and a minimum data set (including blood tests) that is necessary for the monitoring of your treatment.